Phase II study of 3-hour infusion of paclitaxel in patients with previously untreated non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Furuse, K
Naka, N
Ariyoshi, Y
Ikegami, H
Fukuoka, M
Yamakido, M
机构：
[1] NATL SANAT KINKI CENT HOSP,DEPT INTERNAL MED,OSAKA,JAPAN
[2] AICHI CANC CTR HOSP,DEPT CARDIOPULM DIS,AICHI,JAPAN
[3] OSAKA PREFECTURAL MED CTR ADULT DIS,DEPT INTERNAL MED 4,OSAKA,JAPAN
[4] HIROSHIMA UNIV,DEPT INTERNAL MED 2,HIROSHIMA,JAPAN
[5] OSAKA CITY GEN HOSP,DEPT PULM MED,OSAKA,JAPAN
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1072 / 1072
页数：1
相关论文
共 50 条
  • [21] A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer
    Kallab, AM
    Nalamolu, Y
    Dainer, PM
    Jillella, AP
    MEDICAL ONCOLOGY, 2005, 22 (02) : 145 - 151
  • [22] A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer
    Andre Michel Kallab
    Yasolatha Nalamolu
    Paul Maclyn Dainer
    Anand Prasad Jillella
    Medical Oncology, 2005, 22 : 145 - 151
  • [23] Results of a phase 2 study of STA-4783 in combination with paclitaxel and carboplatin in patients with previously untreated advanced non-small cell lung cancer (NSCLC)
    Hainsworth, J
    Weber, R
    Jacobs, M
    Fehrenbacher, L
    Schwartzberg, L
    Kalman, L
    Mills, G
    Dooley, W
    McLeod, M
    Dahl, TA
    Sherman, MS
    Salgia, R
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9059S - 9059S
  • [24] Phase II Study of Biweekly Pemetrexed and Gemcitabine in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer
    Spigel, David R.
    Hainsworth, John D.
    Barton, John H.
    Patton, Jeffrey F.
    Zubkus, John D.
    Simons, Lisa
    Griner, Paula
    Burris, Howard A., III
    Greco, F. Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : 841 - 845
  • [25] Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer
    vonPawel, J
    Wagner, H
    Niederle, N
    Heider, A
    Koschel, G
    Hecker, D
    Hanske, M
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 47 - 50
  • [26] Phase I/II study of weekly docetaxel in patients with previously treated non-small cell lung cancer (NSCLC).
    Hirata, T
    Kawashita, F
    Ogawa, E
    Masago, K
    Kato, M
    Takada, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 676S - 676S
  • [27] Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer
    M J McKeage
    J Von Pawel
    M Reck
    M B Jameson
    M A Rosenthal
    R Sullivan
    D Gibbs
    P N Mainwaring
    M Serke
    J-J Lafitte
    C Chouaid
    L Freitag
    E Quoix
    British Journal of Cancer, 2008, 99 : 2006 - 2012
  • [28] Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer
    Takayama, Koichi
    Ichiki, Masao
    Tokunaga, Shoji
    Inoue, Koji
    Kawasaki, Masayuki
    Uchino, Junji
    Nakanishi, Yoichi
    ONCOLOGIST, 2019, 24 (11): : 1420 - +
  • [29] Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer
    McKeage, M. J.
    Von Pawel, J.
    Reck, M.
    Jameson, M. B.
    Rosenthal, M. A.
    Sullivan, R.
    Gibbs, D.
    Mainwaring, P. N.
    Serke, M.
    Lafitte, J-J
    Chouaid, C.
    Freitag, L.
    Quoix, E.
    BRITISH JOURNAL OF CANCER, 2008, 99 (12) : 2006 - 2012
  • [30] Phase II study of the combination of gemcitabine (G) and nedaplatin (N) for treatment of previously untreated advanced non-small cell lung cancer (NSCLC)
    Shirai, Takao
    Hirose, Takashi
    Horichi, Naoya
    Ando, Kohichi
    Ishida, Hiroo
    Hosaka, Takamichi
    Okuda, Kentaro
    Ohnishi, Tsukasa
    Ohmori, Tohru
    Adachi, Mitsuru
    ANNALS OF ONCOLOGY, 2004, 15 : 175 - 176
12345